Citation Impact
Citing Papers
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels
2008
TGF-β: the master regulator of fibrosis
2016 Standout
Triterpenoids as new promising anticancer drugs
2009 Standout
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Essential thrombocythemia and pregnancy
2011
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia
2006
An Efficient and Robust Statistical Modeling Approach to Discover Differentially Expressed Genes Using Genomic Expression Profiles
2001
Properties and potential of ertapenem
2003
Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic Nephropathy
2009
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
Life and death by death receptors
2009
MINIMUM REDUNDANCY FEATURE SELECTION FROM MICROARRAY GENE EXPRESSION DATA
2005 Standout
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
2001
Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation
1992
A review of feature selection techniques in bioinformatics
2007 Standout
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5
2008
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
2013
Works of Michele Cedrone being referenced
Management of infective complications in patients with advanced hematologic malignancies in home care
1997
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry
2009
Podocalyxin is expressed in normal and leukemic monocytes
2006
Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission
1995
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients
2000
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN
2016
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemia.
1990
TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
2005